A randomized phase II presurgical trial of transdermal 4-hydroxytamoxifen gel versus oral tamoxifen in women with ductal carcinoma in situ of the breast.
about
Biomarkers in phase I-II chemoprevention trials: lessons from the NCI experienceHow do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?Awareness of preventive medication among women at high risk for breast cancer and their willingness to consider transdermal or oral tamoxifen: a focus group study.Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression.Inhibition of breast cancer with transdermal tamoxifen-encapsulated lipoplexMammographic Density as a Biosensor of Tamoxifen Effectiveness in Adjuvant Endocrine Treatment of Breast Cancer: Opportunities and Implications.Cancer Prevention: Lessons Learned and Future Directions.Individualized conditioning regimes in cord blood transplantation: Towards improved and predictable safety and efficacy.The development of targeted new agents to improve the outcome for children with leukemia.Approaches for targeting cancer stem cells drug resistance.Autologous Fat Grafting as a Novel Antiestrogen Vehicle for the Treatment of Breast Cancer.Local delivery of hormonal therapy with silastic tubing for prevention and treatment of breast cancer.Local transdermal therapy to the breast for breast cancer prevention and DCIS therapy: preclinical and clinical evaluation.Breast Cancer Prevention: Current Approaches and Future Directions
P2860
Q26774585-98DC0241-954A-419A-84BF-BECF185919E2Q33767120-865FADA1-454A-47B8-A526-84EB4E18EF6FQ35836307-4B75E023-4951-4C16-879E-686F497898AFQ36181081-E26821C3-4E44-4231-A857-A94B3F9BE612Q36596065-05031401-EE0D-4250-AA4F-2BD58FD805DDQ37130113-11E16E8A-C611-4A56-9900-3A06EA60A425Q38652183-757D4EAC-AB82-459C-AC66-127E76B841FEQ38897538-6F9F06CC-9B6A-49F9-AAEF-0893D51467F6Q38964974-22D669EF-BC33-4946-A2D4-392F800870C9Q38971795-17D9A4E8-4C29-4F77-9919-A0D992F0BAA9Q45986611-BC0A0926-C831-43D3-93A3-7667BBF3F316Q47192770-4A5BB39C-8380-4388-850F-442DF648B728Q53280631-8C1E6A9C-47B4-4F0C-B6B7-24015AF951EDQ57113892-32783A9F-F468-45EF-AA0A-122EDE31F3C5
P2860
A randomized phase II presurgical trial of transdermal 4-hydroxytamoxifen gel versus oral tamoxifen in women with ductal carcinoma in situ of the breast.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A randomized phase II presurgi ...... rcinoma in situ of the breast.
@ast
A randomized phase II presurgi ...... rcinoma in situ of the breast.
@en
type
label
A randomized phase II presurgi ...... rcinoma in situ of the breast.
@ast
A randomized phase II presurgi ...... rcinoma in situ of the breast.
@en
prefLabel
A randomized phase II presurgi ...... rcinoma in situ of the breast.
@ast
A randomized phase II presurgi ...... rcinoma in situ of the breast.
@en
P2093
P2860
P1476
A randomized phase II presurgi ...... rcinoma in situ of the breast.
@en
P2093
Barbara K Dunn
Borko Jovanovic
Brandy M Heckman-Stoddard
David Green
David Ivancic
Irene Helenowski
Jacqueline S Jeruss
Julia Shklovskaya
Julie A Margenthaler
Katherine Page
P2860
P304
P356
10.1158/1078-0432.CCR-13-3045
P407
P577
2014-07-01T00:00:00Z